Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

133.27 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 133.27
Bid (Size) 132.85 (3)
Ask (Size) 133.20 (3)
Prev. Close 133.27
Today's Range 133.27 - 133.27
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
S&P 500, Nasdaq Lurking Below Record Highs
Stocks are scattered this afternoon, as investors digest a weaker-than-expected retail sales reading from May. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a... 
Via Benzinga
Exposures COVID-19

Performance

YTD
+18.46%
+18.46%
1 Month
-5.49%
-5.49%
3 Month
+29.29%
+29.29%
6 Month
+54.62%
+54.62%
1 Year
+7.28%
+7.28%

More News

Read More
The RBA Kept Interest Rates On Hold And Remained Hawkish
Via Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
Via MarketBeat
Exposures COVID-19
Smart Money Is Betting Big In MRNA Options
Via Benzinga
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Via ACCESSWIRE
Moderna Just Gave Investors Another Reason to Buy the Stock
Via The Motley Fool
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Via ACCESSWIRE
7 Struggling Stocks to Sell Before July 2024
Via InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
Via InvestorPlace
Exposures Product Safety
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
What's Going On With Moderna Stock Monday?
Via Benzinga
Exposures COVID-19
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
Via Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Via Investor's Business Daily
Exposures COVID-19
Why Moderna Stock Is a No-Brainer Buy Right Now
Via The Motley Fool
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Via ACCESSWIRE
3 Reasons to Buy Moderna Stock
Via The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Via Benzinga
Exposures COVID-19 Product Safety
5 Stocks Propelling S&P 500 To 25th Record High
Via Talk Markets
Topics Stocks
Exposures US Equities
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Via Benzinga
Novavax Stock’s Recent Surge and Future Potential
Via MarketBeat
Topics Economy
Exposures COVID-19 Product Safety Supply Chain
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program
Via Benzinga
Exposures Product Safety
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
Via InvestorPlace
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.